Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Sitagliptin 100 mg Film-coated Tablets in Healthy Thai Volunteers
TCTR20220317005Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of sitagliptin (2 arms), sponsored by International Bio Service. Primary endpoint: Bioequivalence pharmacokinetic parameters. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
sitagliptin
Beyond the preview
Go deeper on TCTR20220317005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220317005.